University of Sheffield   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Sheffield United Kingdom (1828)

Organization Overview

First Clinical Trial
1995
NCT00002641
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Cancer Research Centre at Weston Park Hospital | Clinical Trials Research Unit, University of Sheffield | Sheffield Children's Hospital and University of Sheffield | The University of Sheffield Medical School

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Endometrial Neoplasms (Phase 3)

Hodgkin Disease (Phase 3)

Kidney Neoplasms (Phase 3)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 3)

Melanoma (Phase 3)

Osteogenesis Imperfecta (Phase 2)

Parkinson Disease (Phase 2)

Pheochromocytoma (Phase 3)

Sarcoma (Phase 3)

Stomach Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 12
  • # of Trial APIs: 23